E van der Wall
Overview
Explore the profile of E van der Wall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
2013
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Binyam D, van Vulpen J, VAN Vulpen J, van Hillegersberg R, van Hillegersberg R, Ruurda J, et al.
Med Sci Sports Exerc
. 2024 Sep;
57(2):327-336.
PMID: 39293388
Purpose: Despite recent treatment advances, esophageal cancer still has poor survival and a high morbidity. Exploratory evidence suggests that exercise can reduce cancer-related mortality and recurrence rates. Here, we investigated...
2.
Janssen L, de Vries B, Janse M, van der Wall E, Elias S, Salgado R, et al.
Breast Cancer Res Treat
. 2024 Sep;
209(1):167-175.
PMID: 39285068
Purpose: In this study, we aimed to explore if the combination of tumor infiltrating lymphocytes (TILs) and change in tumor load on dynamic contrast-enhanced magnetic resonance imaging leads to better...
3.
van Dooijeweert C, Flach R, Ter Hoeve N, Vreuls C, Goldschmeding R, Freund J, et al.
Nat Cancer
. 2024 Jul;
5(8):1285.
PMID: 38969769
No abstract available.
4.
van Dooijeweert C, Flach R, Ter Hoeve N, Vreuls C, Goldschmeding R, Freund J, et al.
Nat Cancer
. 2024 Jun;
5(8):1195-1205.
PMID: 38937624
Pathologists' assessment of sentinel lymph nodes (SNs) for breast cancer (BC) metastases is a treatment-guiding yet labor-intensive and costly task because of the performance of immunohistochemistry (IHC) in morphologically negative...
5.
de Boo L, Jozwiak K, Ter Hoeve N, van Diest P, Opdam M, Wang Y, et al.
ESMO Open
. 2024 Mar;
9(3):102923.
PMID: 38452438
Background: In the absence of prognostic biomarkers, most patients with early-stage triple-negative breast cancer (eTNBC) are treated with combination chemotherapy. The identification of biomarkers to select patients for whom treatment...
6.
Janssen L, Janse M, de Vries B, van der Velden B, Wolters-van der Ben E, van den Bosch S, et al.
NPJ Breast Cancer
. 2024 Jan;
10(1):10.
PMID: 38245552
Accurate prediction of response to neoadjuvant chemotherapy (NAC) can help tailor treatment to individual patients' needs. Little is known about the combination of liquid biopsies and computer extracted features from...
7.
Meijers M, Stouthard J, Evers A, Das E, Drooger H, Jansen S, et al.
Sci Rep
. 2023 Sep;
13(1):16392.
PMID: 37773434
No abstract available.
8.
Koevoets E, Geerlings M, Monninkhof E, Mandl R, Witlox L, van der Wall E, et al.
Neuroimage Clin
. 2022 Dec;
37:103292.
PMID: 36565574
Background: Physical exercise in cancer patients is a promising intervention to improve cognition and increase brain volume, including hippocampal volume. We investigated whether a 6-month exercise intervention primarily impacts total...
9.
Meijers M, Stouthard J, Evers A, Das E, Drooger H, Jansen S, et al.
Sci Rep
. 2022 Sep;
12(1):16112.
PMID: 36167876
To alleviate anti-cancer treatment burden in advanced breast cancer, patient-clinician communication strategies based on nocebo-effect mechanisms are promising. We assessed distinct/combined effects on psychological outcomes (e.g. anxiety; main outcome) and...
10.
Janssen L, den Dekker B, Gilhuijs K, van Diest P, van der Wall E, Elias S
NPJ Breast Cancer
. 2022 Sep;
8(1):107.
PMID: 36123365
This meta-analysis aimed to estimate and compare sensitivity, specificity, positive- (PPV) and negative predictive value (NPV) of magnetic resonance imaging (MRI) for predicting pathological complete remission (pCR) after neoadjuvant chemotherapy...